Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$37,095,027
+$37,095,027 QoQ
Shares Held
39,983
Ownership
0.064%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#75
of 505 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Derivatives in ARGX
reported options exposure · as of Jun 30, 2026CallValue
$3,339,972
CallShares
3,600
PutValue
$2,041,094
PutShares
2,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ARGX ranks #17 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ARGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,041,094 | 2,200 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $3,339,972 | 3,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $37,095,027 | 39,983 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,971,675 | 2,700 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $3,213,100 | 4,400 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $3,784,275 | 4,500 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $4,204,750 | 5,000 | Call | Defined | 2026-02-17 | |
| 2024-12-31 | $91,013,235 | 147,989 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $14,934,429 | 34,728 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $24,883,104 | 63,200 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,928,783 | 118,100 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $123,164,622 | 250,523 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $4,657,250 | 12,500 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $92,958,065 | 263,300 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $217,843,496 | 574,967 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $249,543,901 | 791,424 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $141,354,193 | 403,650 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $86,688,194 | 287,047 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $47,779,809 | 158,700 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $13,631,805 | 49,500 | Shares | Defined | 2021-05-17 | |
| 2020-06-30 | $9,588,942 | 42,574 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||